MAX-LGD – (LGD-4033 LGD-3303 LGD-2226) | GENETIXX LABORATORIES
MAX-LGD – (LGD-4033 LGD-3303 LGD-2226) | GENETIXX LABORATORIES
MAX-LGD
LGD-4033 / LGD-3303 / LGD-2226
Product Overview
MAX-LGD (formerly known MassLGD by Matrix Labs) is a multi-compound research formulation combining three compounds associated with the LGD family of selective androgen receptor modulators (SARMs): LGD-4033, LGD-3303, and LGD-2226.
These compounds have been studied in scientific literature for their interaction with androgen receptors in muscle and bone tissue. Because they belong to the same compound family but display slightly different receptor activity profiles, they are sometimes explored together in experimental models investigating muscle development pathways and strength-related signalling.
MAX-LGD provides a structured capsule format designed for controlled laboratory environments examining multi-compound androgen receptor modulation.
Research Focus
In research settings, compounds within the LGD family are commonly explored in relation to:
• Lean muscle development pathways
• Strength and physical performance signalling
• Muscle preservation during training stress
• Androgen receptor interaction in skeletal muscle tissue
Because LGD-4033, LGD-3303, and LGD-2226 share similar receptor targets, they are sometimes examined together in experimental models investigating compound interaction within the LGD class of SARMs.
Compound Profile
LGD-4033 (Ligandrol)
LGD-4033 is one of the most widely studied SARMs within the LGD compound family. Research literature has explored its interaction with androgen receptors in muscle tissue and its relationship with lean mass development pathways.
LGD-3303
LGD-3303 is another compound within the LGD class of SARMs studied for its interaction with androgen receptors and its potential relationship with muscle development signalling pathways.
LGD-2226
LGD-2226 is an earlier compound investigated in research involving androgen receptor modulation and skeletal muscle development processes.
Product Format
Caps per container: 60
2 capsules contain:
MAX-LGD – 50mg total
• LGD-4033 – 20mg
• LGD-3303 – 20mg
• LGD-2226 – 10mg
Other ingredients:
Gelatin (capsule), Magnesium Stearate, Silicon Dioxide
Why MAX-LGD
MAX-LGD combines three compounds from the same research compound family into a single formulation, allowing experimental protocols to explore potential interaction between multiple LGD-class SARMs within structured research environments.
The capsule format provides a consistent and organised structure for laboratory investigation.
SARMs — RESEARCH USE ONLY
This product is supplied strictly for laboratory research only. It is not approved for human consumption and must not be used as a food supplement or medicine. JW Supplements™ does not provide instructions or dosage guidance for human use.
⚠️ IMPORTANT PRODUCT INFORMATION
Please read the product description and any product-specific warnings before purchasing. Products have different intended purposes and restrictions; refer to the information for the individual product.
Foods and supplements: Before consumption, read the ingredients, allergen information and warnings on the product packaging. JW Supplements™ does not provide personalised medical advice.
Food supplements: Follow the labelled directions and do not exceed the recommended daily intake. Food supplements should not replace a varied, balanced diet and a healthy lifestyle. Consult a qualified healthcare professional before taking a supplement if you have a medical condition, take medication, are pregnant or breastfeeding, or are unsure about suitability.
Topical products: Not for oral consumption. Follow the product-specific purpose, restrictions and warnings. Products identified as research-only must not be applied to people.
Age restriction: JW Supplements™ restricts sales to individuals aged 18 or over.
Storage: Follow the storage instructions on the packaging. Keep out of reach of children and pets.
For enquiries, contact enquiries@jwsupplements.co.uk.
Share
